Related Experiment Video

Updated: Jun 23, 2026

Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

GABA receptor expression in benign and malignant thyroid tumors

Stephen S Roberts1, Maria Cecilia Mendonça-Torres, Kirk Jensen

  • 1Department of Pediatrics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA. sroberts@usuhs.mil

Pathology Oncology Research : POR
|April 22, 2009
PubMed

Insights

This study reveals increased gamma-aminobutyric acid (GABA) receptor expression in thyroid tumors, suggesting the GABAergic system plays a role in thyroid carcinogenesis and potentially early tumor development.

Area of Science:

  • Neuroscience
  • Oncology
  • Molecular Biology

Background:

  • Neurotransmitter systems are implicated in various cancers.
  • The involvement of neurotransmitters in thyroid cancer remains largely unexplored.
  • Gamma-aminobutyric acid (GABA) is a key inhibitory neurotransmitter.

Purpose of the Study:

  • To investigate the expression patterns of GABA receptors in normal thyroid tissue and thyroid tumors.
  • To determine the potential role of the GABAergic system in thyroid carcinogenesis.

Main Methods:

  • Immunohistochemistry was used to examine GABA receptor expression in 70 human thyroid tumor samples and adjacent normal tissue.
  • Real-time PCR analyzed GABAergic system mRNA expression in thyroid cancer cell lines.

Main Results:

  • GABA receptor expression was generally elevated in thyroid tumors compared to normal tissue.
  • Specific GABA receptor subunits (GABAA alpha2, GABAB R2, GABARAP) showed altered expression patterns in tumors and cell lines.
  • GABAA receptor beta2 was found in the vasculature but not in thyroid cancer cells.

Conclusions:

  • This study provides the first evidence of GABA receptor expression in human thyroid tissue.
  • The GABAergic system appears to be involved in thyroid carcinogenesis, potentially influencing early stages of tumor development.

Related Concept Videos

Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...